Purchased high profile positive and negative antibiotic disc containing Amoxicillin, Perfloxacin, Erythromycin, Septrin, Streptomycin, Ciprofloxacin, Rocephin, Zinnacef, Ampiclox, Gentamycin, Spafloxacin, Chloramphenicol, Augmentin and Tarivid each of different concentration were tested on the identified bacteria isolates by disc diffusion method(Fadila and Tajelmolk, 2016) These antibiotics were tested because they seem to be common in Nigerian markets.
Table 1
Susceptibility pattern of antibiotics against different microorganisms.
S/N | Bacteria | (µg) | Streptococcus spp | S.aureus | Salmonella Spp | Shigella Spp | E. coli |
1 | Amoxicillin | 30 | + | - | - | - | - |
2 | Perfloxacin | 10 | ++ | +++ | - | ++ | +++ |
3 | Erythromycin | 10 | ++ | NT | NT | NT | NT |
4 | Septrin | 30 | +++ | +++ | - | + | + |
5 | Streptomycin | 30 | +++ | +++ | - | + | ++ |
6 | Ciprofloxacin | 10 | +++ | +++ | - | +++ | +++ |
7 | Rocephin | 25 | - | +++ | NT | NT | NT |
8 | Zinnacef | 20 | - | NT | NT | NT | NT |
9 | Ampiclox | 20 | - | NT | NT | NT | NT |
10 | Gentamycin | 10 | ++ | NT | + | ++ | +++ |
11 | Spafloxacin | 10 | NT | ++ | - | ++ | ++ |
12 | Chloramphenicol | 30 | NT | ++ | - | - | + |
13 | Augmentin | 30 | NT | - | - | - | + |
14 | Tarivid | 10 | NT | - | - | + | + |
# Diameter of inhibition zone: NT; Not tested, no inhibition (-); 5–15 mm (+); 16–25 mm (+ +); 26–35 mm (+ + +) |
Streptococcus spp, were resistant to rocephine, zinnacef and ampiclox at 20 µg and showed little activity for amoxil. S. aureus showed resistance to 10 µg tarivid, 30 µg of amoxicillin and augmentin. Salmonella spp, were resistant to all tested antibiotic but gentamycin at 10 µg. Shigella spp showed resistance to 30 µg of amoxicillin, chloramphenicol and augmentin. Escherichia Coli was only resistant to amoxiciln at 30 µg.
3.1 Antibacterial activity of Amx, AmxA, AmxM, AmxB, Ap, ApA, ApM, and ApB
The antimicrobial susceptibility test in Table 1 shows a zone of inhibition (ZOI) of 0 mm for 1 g/mL of amoxicillin against all four of the bacterial strain, which were increased to a minimum value of 16.7 ± 1.2 mm for Salmonella spp and a maximum of 21.3 ± 1.2 mm for S. aureus due to the acid influence in the combination process.
Table 2
Zone of inhibition (mm) of resistant bacterial strains in response to Amx, AmxA, AmxM, AmxB, Ap, ApA, ApM, and ApB.
S/N | Bacteria | Amx | Ap | AmxA | ApA | AmxB | ApB | AmxM | ApM |
1 | Salmonella spp | 0 | 5.6 ± 0.3 | 16.7 ± 1.2 | 17.4 ± 1 | 5.8 ± 0.6 | 0 | 5.5 ± 0.4 | 0 |
2 | Shigella spp | 0 | 5.8 ± 0.5 | 15.4 ± 0.9 | 16.6 ± 0.7 | 0 | 5.3–0.5 | 0 | 5.1 ± 0.3 |
3 | S. aureus | 0 | 0 | 16.2 ± 0.8 | 25.9 ± 1.2 | 0 | 0 | 5.0 ± 0.2 | 16.8 ± 0.8 |
4 | E. coli | 0 | 10.8 ± 1.2 | 21.3 ± 1.2 | 18.3 ± 0.8 | 0 | 0 | 0 | 13.4 ± 0.9 |
Ampicillin at 1 mg/mL shown a ZOI of 0 mm for S. aureus, 5.6 ± 0.3 mm for Salmonella, 5.8 ± 0.5 mm for Shigella and 10.8 ± 1.2 mm for S. aureus but, it acid enhanced combination showed a minimum increase of + 7.5 mm for S. aureus and + 25.9 mm for E. coli. All the acid combinatorial synthesis showed a synergistic effect against all the tested bacteria and successfully overcame resistance presented by the tested strains, this may be due to possible conjugation of some of the functional groups or substituents of either the antibiotic and the different phytochemicals present in the plant extract, Fig. 5 confirms a reaction in the mixture with a colour change from light green to brown. (Reusch, 2013)
No observable changes in ZOI of alkali combinatorial synthesis, this may be due to the conjugation or possible substitution of the active sites of either the antibiotic or the phytochemicals themselves, with a colour change from light green to a dark green cloudy solution.
The heat catalysed mixture of both antibiotics were able to overcome resistance with ZOI increase from 0 to 5.5 ± 0.4 mm for salmonella spp, 0 to 5.0 ± 0.2 E. coli in amoxicillin and a + 16.8 mm increase in S. aureus for ampicillin only, thus confirming the antimicrobial properties exhibited by the plant Calotropis procera extract (Barkha et al, 2021)
3.2 Validation of positive results
The validation of positive results obtained from the first combinatorial synthesis method as shown in Fig. 5 and Table 2 were carried out using a different plant extract of Piliostigma reticulatum (Boualam et al, 2021), with an additional antibiotic ( azithromycin) and an additional bacteria strain ( streptococcus spp )
The acid catalysed combinations were still able to overcome resistance in Streptococcus spp for azithromycin, in streptococcus spp and S. aureus also for ampicillin with a minimum ZOI of 11.3 mm and a maximum ZOI of 22.4 mm, an increased in ZOI from 11.3 mm to 22.4 mm was observed in streptococcus spp. An increase in ZOI with increase in acid volume were observed in Streptococcus spp as shown in Table 3.
Table 3
Zone of inhibition (mm) of 3 resistant bacterial strains in response to A, A1, A2, A3, B, B1, B2 and B3
S/N | Bacteria | A | A1 | A2 | A3 | B | B1 | B2 | B3 |
1 | Streptococcus spp | 0 | 11.3 ± 1.5 | 15.5 ± 1.5 | 22.4 ± 1.2 | 0 | 13.5 ± 0.8 | 19.7 ± 1 | 21.2 ± .9 |
2 | S. aureus | 13.40 ± 0.9 | 21.4 ± 1.2 | 19.2 ± 0.7 | 21.1 ± 1.1 | 0 | 12.2 ± 0.9 | 17.2 ± 1.2 | 16.6 ± 0.8 |
3 | Salmonella spp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No ZOI was observed in salmonella spp, this may be due to the nature of phytochemicals present in Piliostigma reticulatum or may be no fresh leaves were used. Piliostigma reticulatum is commonly used to treat fungal infection while Calotropis is used to treat typhoid fever as practiced in Nigeria. This further confirms the necessity of prerequisite knowledge of the plant ethnopharmacolgical usage and also that of the resistant pathogen before any combinatorial method.
A decrease in colour intensity and smell were observed with successive addition of acid from 0.1 to 0.3 ml as shown in Fig. 6, at 0.3 mL no smell were detected in the case of ampicillin, implying at 0.1 and 0.2 ml of acid added the antibiotic still retains some of the functional groups or substituents responsible for it characteristic smell, but on addition of another 0.1 ml of acid the smell disappeared, indicating that particular functional groups or substituents were definitely involved in conjugation or might be substituted.
Table 4
Comparison of acid enhanced combination with other methods for resistant bacteria inhibition
Bacteria strain | Antibiotic | Antibiotic MIC | Mixture MIC | Ref |
P. chlororaphis P. monteilii | Cefotaxime Rifampicin | Nil Nil | 12.5µg/ml 0.195 µg/ml | Haq et al (2019) |
E. coli S. enteritidis | Ticarcilin 5 µg/ml | Nil Nil | 16.00 mm 18.33 mm | Fadila and Tajelmol (2016) |
E. coli S. aureus | Chloramphenicol30 µg Tetracycline 30 µg | Nil Nil | 11.00 mm 12.00 mm | Eze et al (2013) |
The former combinatorial method as shown in Table 4 is a trial based on probability approach where the combination may or may not inhibit bacterial growth with the effect being either additive, antagonistic or synergistic even with the right medicinal plants, but in acid catalyze methods at lower concentration with the right medicinal plants there is higher possibility that all combinations will be synergistic